Luwad, Norpa .

HRN: 25-78-45  Sex: Female

Patient Encounter


AMS Audit List

Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
08/30/2024
PIPERACILLIN + TAZOBACTAM 2.25G (VIAL)
08/30/2024
09/06/2024
IV
4.5g
Q8h
Pneumonia
Waiting Final Action 
08/31/2024
PIPERACILLIN + TAZOBACTAM 2.25G (VIAL)
08/31/2024
09/06/2024
IV
2.25g
Q8h
CAPMR
Rejected 
08/31/2024
AZITHROMYCIN 500MG TABLET (TAB)
08/31/2024
09/02/2024
PO
500mg OD
Once Daily
CAPMR
Waiting Final Action 

AMS Audit Form


Start Date: End Date:

Indication:

              

Type of Infection:

                             

           

Compliance to guidelines:



Initial appropriateness:



 If inappropriate:

           

Final appropriateness:



 If inappropriate:

              

Overall appropriateness: